Task order 4A site study setup: cancer trials support unit (ctsu) IDIQ
Active Awarded Last action
- Contract number
- 75N91022F00002
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,552,799
Award facts
- Opportunity
-
- Cancer Trials Support Unit Pre-Solicitation · Posted Sep 10, 2021
- Contract value 61% obligated
-
- $8,417,703.00 Current, with exercised options
- $12,295,591.00 Potential, with all options
- Completion date 85% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,600,000 | |
| Exercise an Option | $1,545,000 | |
| Exercise an Option | $1,500,000 | |
| Exercise an Option | $1,250,000 | |
| Other Administrative Action | $0 | |
| Original award | $1,657,799 |
About this award
The National Cancer Institute issued a delivery order to Westat, Inc. on August 1, 2022, with a ceiling value of $12.3 million under the Cancer Trials Support Unit IDIQ, supporting site study setup for cancer clinical trials.
The Cancer Trials Support Unit is a single-award IDIQ administered by the National Cancer Institute for research coordination, data collection, statistical analysis, and program evaluation services. Place of performance is Rockville, MD. The order runs through July 31, 2027, under a cost-plus-fixed-fee pricing structure.
As of FY2024, Westat has invoiced $1.2 million across 8.5 FTEs and 17,603 contractor hours, reflecting a derived government-paid hourly rate of $67.31. The contractor self-performed all reported labor with no subcontractors. Invoiced volume increased sharply from FY2022 ($21 thousand) to FY2023 ($1.3 million), then remained relatively stable in FY2024. Derived hourly rates declined from $79.65 in FY2022 to $64.44 in FY2023 before rising slightly to $67.31 in FY2024.
Quick answers
Who was awarded contract 75N91022F00002?
75N91022F00002 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2022.
How much is contract 75N91022F00002 worth?
The government has obligated $7,552,799 on 75N91022F00002. Its current value, with exercised options, is $8,417,703. Its potential value, with all options, is $12,295,591.
Is contract 75N91022F00002 an order under another contract?
Yes. 75N91022F00002 is a delivery order under 75N91022D00009, an indefinite delivery contract, on Cancer Trials Support Unit.
Was contract 75N91022F00002 competed?
The extent of competition for 75N91022F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award